Fatima bint Mubarak Center celebrates one year of pioneering cancer care in the UAE

UAE—The Cleveland Clinic Abu Dhabi, part of the M42 network, celebrated the Fatima bint Mubarak Center’s first year of pioneering cancer care in the region.

His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, launched this center in March 2023, exhibiting a cutting-edge facility aimed to deliver advanced, world-class customized care for cancer patients in the UAE and the wider region.

In its first year, the Fatima bint Mubarak Center saw over 3,000 new cancer patients, facilitated over 30,000 clinic visits, administered 6,000 radiation treatments, 6,500 chemotherapy infusions, and conducted 7,000 imaging examinations.

The Fatima bint Mubarak Center, modeled after Cleveland Clinic’s Taussig Cancer Center, is one of the top cancer institutions in the United States. It provides a multidisciplinary approach to cancer care.

Throughout a patient’s journey, it inspires hope, compassion, and medical expertise, with the goal of improving their outcomes and quality of life.

Dr. Stephen Grobmyer, Chair of Cleveland Clinic Abu Dhabi’s Oncology Institute, stated that the Center demonstrates the organization’s consistent commitment to advancing cancer care in the region.

He also stressed that it is a year of partnership that will develop their comprehensive approach to cancer treatment.

Inspired by the UAE leadership’s goal, Grobmyer believes that patients and their families will gain while cancer continues to claim millions of lives each year.

The Center will continue to fight the disease while also helping to shape the future of medical care, one innovation at a time.

In accordance with Cleveland Clinic Abu Dhabi’s patient-first perspective, the multidisciplinary oncology team at the Fatima bint Mubarak Center, known for their wide skill set and specialized knowledge, guarantees a thorough approach to treatment planning.

The team’s commitment to excellence is proven via ongoing efforts to improve the quality and safety of sustainable healthcare, which is tailored to each individual’s history and condition.

The three-year accreditation from the Joint Commission International (JCI) recognizes this unwavering commitment.

Moreover, the Fatima bint Mubarak Center has excelled in providing a variety of technology-first solutions, such as adaptive radiotherapy, which combines artificial intelligence (AI) and machine learning to modify a patient’s treatment plan in real-time based on daily changes in the patient’s anatomy.

Additionally, radioembolization, or TARE-Y90 therapy, is a minimally invasive targeted therapy that uses radioactive particles to eliminate cancer cells in the liver, providing patients with a higher quality of life and a longer lifespan.

 In addition, early this year, the clinic debuted High-Intensity Focused Ultrasound (HIFU), a new non-surgical therapy that provides prostate cancer patients with a minimally invasive treatment option.

The Fatima bint Mubarak Center anticipates a future dedicated to cancer research, teaching, and providing unmatched patient care.

Using cutting-edge technologies such as generative AI, virtual reality, and augmented reality, as well as predictive analytics, the centre hopes to improve the precision and effectiveness of healthcare interventions, contributing significantly to the global struggle against cancer.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.